Skip to main content

Table 2 Glucometabolic state and lipid profile of the 3 groups

From: Impact of post-challenge hyperglycemia on clinical outcomes in japanese patients with stable angina undergoing percutaneous coronary intervention

  DM (n=452) PH (n=236) NGT (n=140) P value
Glucometabolic state     
FPG, mg/dl 140.0 (111.2-194.0)*† 94.0 (88.0-101.7)† 86.0 (82.2-91.0) <0.001
2-h PG, mg/dl - 189.5 (161.0-224.2)† 116.0 (97.0-128.0) <0.001
HbA1c, % 7.3 (6.8-8.3)*† 6.0 (5.8-6.3)† 5.8 (5.6-6.0) <0.001
Lipid profile, mg/dl     
Total choresterol 181 (156–207.7) 176 (155.2-196.7) 177.5 (158.2-203.7) 0.37
Triglyceride 131.5 (94–194) 132 (101.2-178.7) 117 (91.5-162) 0.12
HDL-C 47 (40–55) 44 (37–51)†‡ 47.5 (39–57) 0.001
LDL-C 104 (85–126.7) 106.5 (88.2-126) 105.5 (88–125.7) 0.64
  1. Values are expressed as medians (interquartile range). *P <0.05 vs. PH; †P <0.05 vs. NGT; and ‡P <0.05 vs. DM.
  2. FPG, fasting plasma glucose; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; PG, plasma glucose. Other abbreviations as in Table 1.